Bevacizumab is a recombinant humanized monoclonal antibody that blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A). VEGF-A is a chemical signal that stimulates angiogenesis in a variety of diseases, especially in cancer.
Use in Cancer. Bevacizumab is approved to be used alone or with other drugs to treat: 1  Cervical cancer that has not gotten better with other treatment, has metastasized (spread to other parts of the body), or has recurred (come back).
Avastin is the brand name for the anti-cancer medication bevacizumab, which belongs to a group of drugs called monoclonal antibodies.
IMPORTANT WARNING: Bevacizumab may cause you to develop a hole in the wall of your stomach or intestine. This is a serious and possibly life-threatening condition. If you experience any of the following symptoms, call your doctor immediately: stomach pain, constipation, nausea, vomiting, or fever.
Bevacizumab (pronounced /bev-a-Sizz-uh-mab/, trade name Avastin, Genentech / Roche) is an angiogenesis inhibitor, a drug that slows the growth of new blood vessels.
Avastin. Generic name: Bevacizumab. Chemocare.com uses generic names in all descriptions of drugs. Avastin is the trade name for Bevacizumab. In some cases, health care professionals may use the trade name Avastin when referring to the generic drug name Bevacizumab. Drug type: Avastin is classified as a monoclonal antibody and anti-angiogenesis drug. (For more detail, see How this drug works section below.).
Bevacizumab injection is given with other medicines to treat patients with metastatic (a cancer that has spread) carcinoma of the colon or rectum.